97265 ⎘
Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
Antibody dual display dual compositions and methods of use thereof
#302Complex-specific antibodies and antibody fragments and its use
#303Use of Macrophage inflammatory protein-1Beta (MIP-1Beta) inhibitor to protect pancreas and prevent blood sugar from rising
#304Methods for the generation of multispecific and multivalent antibodies
#305BINDING MOLECULES TARGETING PATHOGENS
#306Antibodies that bind interleukin-2 and uses thereof
#307Anti-IL-6/IL-6R antibodies and methods of use thereof
#308HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES
#309POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS
#310T cell receptors and immune therapy using the same
#311System with buffer for lateral flow on a porous membrane
#312Anti-NGF antibodies and anti-NGF antibody fragments
#313Antibodies against notch 3
#314Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies
#315System with liquid and solid media for target binding
#316TfR selective binding compounds and related methods
#317Chimeric antigen receptors (CAR) to selectively target protein complexes
#318ANTI-LIGHT ANTIBODIES
#319Anti-LIGHT antibodies
#320ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS
#321Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
#322ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY
#323Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
#324Anti-LAG3 antibodies and antigen-binding fragments
#325Combination Therapy For Treatment of Cancer
#326TREATMENT OF TAUOPATHIES
#327Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#328ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
#329Compositions and methods for growth factor modulation
#330Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#331Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
#332THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS
#333CTLA4 binders
#334Anti-alpha-synuclein antibodies and methods of use
#335Anti-WT1/HLA-specific antibodies
#336METHODS AND COMPOSITIONS RELATED TO AMYLOID-BETA-42 OLIGOMERS
#337IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#338Diagnostic anti-CD95L antibody
#339Compositions and methods relating to Lyme disease
#340Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof
#341Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof
#342COMPOSITION AND METHOD FOR DETECTING MALIGNANT NEOPLASTIC DISEASE
#343Tight-binding agents and uses thereof
#344Human cytomegalovirus neutralising antibodies and use thereof
#345Computationally optimized broadly reactive antigens for H5N1 and H1N1 influenza viruses
#346Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody
#347Methods of purifying bispecific antibodies
#348Anti-HIV domain antibodies and method of making and using same
#349Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof
#350Antibodies which bind type I cannabinoid receptor/angiotensin II receptor heteromers and methods of use
#351Human FcRn-binding modified antibodies and methods of use
#352Anti-IL-6/IL-6R antibodies
#353GENERATION OF HIGHLY POTENT ANTIBODIES NEUTRALIZING THE LUKGH (LUKAB) TOXIN OF STAPHYLOCOCCUS AUREUS
#354Composition and method for preventing or treating a tauopathy
#355Monoclonal antibodies against antithrombin β
#356Modulators
#357Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
#358Human CGRP receptor binding proteins
#359Anti-CD83 antibodies and use thereof
#360Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#361MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF
#362Method and kit for detecting 1,25-dihydroxyvitamin D and related antibodies
#363Methods of preventing or treating pain using anti-NGF antibodies
#364Anti-factor XI monoclonal antibodies and methods of use thereof
#365Modulators
#366Compositions and methods relating to lyme disease
#367Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
#368Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
#369Antibodies directed to IL-17A/IL-17F heterodimers
#370Immunoassay kit for quantification of BNP and proBNP
#371Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
#372Antibody against transporter and use thereof
#373Anti-alpha-synuclein antibodies and methods of use
#374Methods of using an alpha-4-beta-7 heterodimer specific antagonist antibody
#375Use of an anti-Ang2 antibody
#376Biochemical markers for neurodegenerative conditions
#377Aberrant cell-restricted immunoglobulins provided with a toxic moiety
#378Antibody against affinity complex
#379NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#380Antibodies immunoreactive with heregulin-coupled HER3
#381Neutralizing antibodies and methods of use thereof
#382Anti-drug antibody assay
#383MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS
#384Neutralizing antibodies and methods of use thereof
#385HLA-restricted, peptide-specific antigen binding proteins
#386Monoclonal antibodies against antithrombin β
#387Polypeptide that binds aberrant cells and induces apoptosis
#388Methods and compositions for targeting polyubiquitin
#389Methods for the generation of multispecific and multivalent antibodies
#390TCR mimic antibodies as vascular targeting tools
#391Cross-linking polypeptide that induces apoptosis
#392Marker comprising anti-CK8/18 complex autoantibody and its use for diagnosing cancer
#393Human cytomegalovirus neutralising antibodies and use thereof
#394HLA-restricted, peptide-specific antigen binding proteins
#395Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy
#396Methods of purifying antibodies
#397Alpha-4-beta-7 heterodimer specific antagonist antibody
#398Human cytomegalovirus neutralising antibodies and use thereof
#399Antibodies which bind type I cannabinoid receptor/angiotensis II receptor heteromers
#400Human FGF receptor and β-Klotho binding proteins
#401Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
#402NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#403Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
#404Anti-IL-23 heterodimer specific antibodies
#405Antibody for the diagnosis and/or prognosis of cancer
#406Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
#407Human CGRP Receptor Binding Proteins
#408Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
#409Cancer-related glycopeptide epitopes, antibodies and methods of use
#410Monoclonal antibodies and method of immunological analysis of D-dimer
#411Broadly cross-reactive HIV-1 Env-specific antibodies
#412TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#413Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
#414Hepatitis B virus specific antibody and uses thereof
#415Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof
#416ENV POLYPEPTIDE COMPLEXES AND METHODS OF USE
#417Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics
#418Polynucleotides encoding anti-factor XI monoclonal antibodies and methods of use thereof
#419BIPARATOPIC PROTEIN CONSTRUCTS DIRECTED AGAINST IL-23
#420TREATMENT OF TAUOPATHIES
#421Treatment of tauopathies
#422Non-naturally occurring T cell receptors
#423Methods for producing cytokine receptor ZALPHA11
#424Detection of amyloid deposits using anti-amyloid antibodies
#425Methods for the generation of multispecific and multivalent antibodies
#426Alpha-4-beta-7 heterodimer specific antagonist antibody
#427Alpha-4-beta-7 heterodimer specific antagonist antibody
#428Bispecific binding agents for modulating biological activity
#429Compositions and methods for the therapy and diagnosis of influenza
#430Therapeutic compositions and methods for the prevention of autoimmune diseases
#431Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
#432Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#433Neutralizing antibodies and methods of use thereof
#434Composition and method for treating a tauopathy
#435Monoclonal antibodies capable of simultaneously binding domains II and IIIc of type 1 fibroblast growth factor receptor
#436POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#437ANTIBODIES AS T CELL RECEPTOR MIMICS, METHODS OF PRODUCTION AND USES THEREOF
#438NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#439Human cytomegalovirus neutralising antibodies and use thereof
#440Human cytomegalovirus neutralising antibodies and use thereof
#441ASSAY FOR DETECTING VITAMIN D AND ANTIBODIES THEREFOR
#442Peptidic antigen that induces antibody recognizing three-dimensional structure of HIV and method for synthesizing same
#443Anti-amyloid antibodies
#444Anti-IL6/IL-6R antibodies
#445IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#446ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS
#447ANTIBODIES AS T CELL RECEPTOR MIMICS, METHODS OF PRODUCTION AND USES THEREOF
#448SPECIFIC BINDING PROTEINS AND USES THEREOF
#449Methods and materials for assessing enzyme-nucleic acid complexes
#450Anti-hepsin antibodies and methods using same
#451TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#452Chimeric, humanized, or human antibody 2A4
#453Conformation specific antibodies
#454IMMUNOGLOBULIN CONSTRUCTS
#455Methods for detecting modulators of cytokine receptor zalpha11
#456Mammalian Cytokines; Related Reagents and Methods
#457Modified anti-heparin/PF4 complex antibody and HIT antibody standard
#458BIOMARKER DETECTION-2
#459Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#460Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof
#461Anti-HIV domain antibodies and method of making and using same
#462Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#463Modulators
#464SPECIFIC BINDING PROTEINS AND USES THEREOF
#465Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
#466AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME
#467Antibodies to interleukin-6
#468Treatment and prophylaxis of amyloidosis
#469COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA
#470ANTI INFLUENZA ANTIBODIES AND USES THEREOF
#471METHOD FOR OBTAINING POLYPEPTIDE CONSTRUCTS COMPRISING TWO OR MORE SINGLE DOMAIN ANTIBODIES
#472Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
#473Cobalamin assay
#474Anti human immunodeficiency antibodies and uses thereof
#475Anti-factor XI monoclonal antibodies and methods of use thereof
#476Anti-IL-6/IL-6R antibodies and methods of use thereof
#477HIV-1 envelope glycoprotein oligomer and methods of use
#478Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#479Antibodies immunoreactive with heregulin-coupled HER3
#480Serum Prolactin Binding Protein in Epithelial Carcinoma
#481ANTIBODY HAVING INHIBITORY EFFECT ON AMYLOID FIBRIL FORMATION
#482Methods and compositions for targeting polyubiquitin
#483Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#484Engineered proteins with high affinity for DOTA chelates
#485Alpha-4 beta-7 heterodimer specific antagonist antibody
#486CHAIN REACTION CREATING OLIGOMERS FROM REPEAT UNITS OF BINDING MOLECULES
#487Antibodies to cytokine receptor zalpha11
#488Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
#489Methods of using neutralizing anti-TLR4/MD2 antibodies
#490Compositions and methods for the therapy and diagnosis of influenza
#491Human CGRP receptor binding proteins
#492ANTIBODIES, METHODS AND KITS FOR DIAGNOSING AND TREATING MELANOMA
#493Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
#494Transcobalamin II assay method
#495Antibodies for determining the prothrombin fragment F2/F1+2 in a homogeneous immunoassay
#496ANTI-DRUG ANTIBODY ASSAY
#497Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
#498Antibodies as T cell receptor mimics, methods of production and uses thereof
#499Methods of assaying vaccine potency
#500Antibodies as T cell receptor mimics, methods of production and uses thereof
#501Compositions and methods for the therapy and diagnosis of influenza
#502Use of HIV envelope/CD4 complexes for the generation antibodies
#503Chimeric, humanized, or human antibody 2A4
#504Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
#505Bispecific binding agents for modulating biological activity
#506Use of Toll-Like Receptor 4 Antagonists for the Treatment or Prevention of Osteoarthritic Conditions
#507Antibody having inhibitory effect on amyloid fibril formation
#508Human cytomegalovirus neutralising antibodies and use thereof
#509METHODS OF ASSAYING VACCINE POTENCY
#510Antibodies at T cell receptor mimics, methods of production and uses thereof
#511IMMUNE COMPLEX VACCINATION AS A STRATEGY TO ENHANCE IMMUNITY IN THE ELDERLY AND OTHER IMMUNE COMPROMISED POPULATIONS
#512Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism
#513Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#514COMPOUNDS CAPABLE OF INHIBITING HIV-1 INFECTION
#515Human cytomegalovirus neutralizing antibodies and use thereof
#516Env polypeptide complexes and methods of use
#517IL-17A/F heterologous polypeptides and therapeutic uses thereof
#518Neutralizing antibodies and methods of use thereof
#519Molecular scaffolds for HIV-1 epitopes
#520Conformation specific antibodies
#521Neutralizing antibodies and methods of use thereof
#522Methods of using novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
#523Polynucleotides encoding anticoagulant fusion proteins
#524Methods and compositions for targeting polyubiquitin
#525METHODS FOR DETECTING MODULATORS OF CYTOKINE RECEPTOR ZALPHA11
#526METHODS FOR DETECTING MODULATORS OF CYTOKINE RECEPTOR ZALPHA11
#527Methods of treating cancer comprising administering an interleukin-6 antibody variable region
#528Antibodies to cytokine receptor zalpha11
#529CYTOKINE RECEPTOR ZALPHA11
#530Serum Prolactin Binding Protein in Epithelial Carcinoma
#531Antibodies as T cell receptor mimics, methods of production and uses thereof
#532Method of isolating cytotoxic heterocomplex associated with multiple sclerosis
#533IL-12P40 and IL-B30 polypeptide complex
#534EGR-EGFR complex
#535Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
#536Compounds capable of inhibiting HIV-1 infection
#537Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#538IL-17A/F heterologous polypeptides and therapeutic uses thereof
#539Cobalamin assay
#540Pharmaceutical compositions comprising an hiv envelope protein and cd4
#541Use of heat shock proteins to enhance efficacy of antibody therapeutics
#542Anti-HIV composition, production method thereof and medicament
#543Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
#544Immunoassays for determining vitamin B12, and reagents and kits therefor
#545Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis
#546Antibodies as T cell receptor mimics, methods of production and uses thereof
#547PSP94 diagnostic reagents and assays
#548Neutralizing antibodies and methods of use thereof
#549Methods and compositions based on protein interactions with mastermind
#550Fluorescence analysis method using fluorescent-activating antibodies
#551Cellular virus receptors and methods of use
#552Methods of using cytokine receptor zalpha11 to detect its ligands